2020
GBS Inc. Nasdaq IPO
OncoTEX team publishes landmark OxaliTEX preclinical trial findings in Proceedings of the National Academy of Sciences (PNAS).
iQNovate Ltd (NSX:IQN) name change to The iQ Group Global Ltd (NSX:IQG)
OncoTEX team publishes landmark OxaliTEX preclinical trial findings in Proceedings of the National Academy of Sciences (PNAS).
iQNovate Ltd (NSX:IQN) name change to The iQ Group Global Ltd (NSX:IQG)
2019
The iQ Group Global acquires TEX Core, an oncology drug platform
Recognised as one of Australia and New Zealand’s Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine
FarmaForce wins Sales Team of the Year at PRIME Awards for the third time
Capital Labs raises more than $828,000 for healthcare startup
Recognised as one of Australia and New Zealand’s Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine
FarmaForce wins Sales Team of the Year at PRIME Awards for the third time
Capital Labs raises more than $828,000 for healthcare startup
2018
China patent granted for Saliva Glucose Biosensor
FarmaForce wins Sales Team of the Year at PRIME Awards for the second time
FarmaForce wins Sales Team of the Year at PRIME Awards for the second time
2017
US patent granted for Saliva Glucose Biosensor
2016
The iQ Group Global accelerated the development of the Saliva Glucose Biosensor
iQ Capital incorporated in the USA
Series 8 Fund launched
FarmaForce wins Sales Team of the Year at PRIME Awards
iQ Capital incorporated in the USA
Series 8 Fund launched
FarmaForce wins Sales Team of the Year at PRIME Awards
2015
2014
Inception of CRC and FarmaForce
2012
iQnovate commences trading in the USA
2010
Inception of iQnovate